Page last updated: 2024-08-17

bromodeoxyuridine and Keratosis, Seborrheic

bromodeoxyuridine has been researched along with Keratosis, Seborrheic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanche, M; Dunois-Lardé, C; Gasc, JM; Jorcano, J; Levrel, O; Logié, A; Radvanyi, F; Ribeiro, A; Rosty, C; Sastre-Garau, X; Thiery, JP; Werner, S	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Keratosis, Seborrheic

Article	Year
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Human molecular genetics, 2005, May-01, Volume: 14, Issue:9 Topics: Animals; Bromodeoxyuridine; DNA Mutational Analysis; Gene Expression; Humans; Immunohistochemistry; Keratosis, Seborrheic; Mice; Mice, Transgenic; Point Mutation; Polymorphism, Single-Stranded Conformational; Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Skin Neoplasms; Transgenes	2005

Article

Year

Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.

Human molecular genetics, 2005, May-01, Volume: 14, Issue:9

Topics: Animals; Bromodeoxyuridine; DNA Mutational Analysis; Gene Expression; Humans; Immunohistochemistry; Keratosis, Seborrheic; Mice; Mice, Transgenic; Point Mutation; Polymorphism, Single-Stranded Conformational; Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Skin Neoplasms; Transgenes

2005